Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/27696387
Conclusion of this study
Although double-blind, placebo-controlled trials are still necessary, these findings suggest that cannabidiol may be an effective and well-tolerated treatment option for patients with refractory seizures in TSC.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
